Cargando…

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

BACKGROUND: Normofractionated radiation regimes for definitive prostate cancer treatment usually extend over 7–8 weeks. Recently, moderate hypofractionation with doses per fraction between 2.2 and 4 Gy has been shown to be safe and feasible with oncologic non-inferiority compared to normofractionati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ristau, J., Hörner-Rieber, J., Buchele, C., Klüter, S., Jäkel, C., Baumann, L., Andratschke, N., Garcia Schüler, H., Guckenberger, M., Li, M., Niyazi, M., Belka, C., Herfarth, K., Debus, J., Koerber, S. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011377/ https://www.ncbi.nlm.nih.gov/pubmed/35428327 http://dx.doi.org/10.1186/s13014-022-02047-w

Ejemplares similares

MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)
por: Pavic, M., et al.
Publicado: (2022)

Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021)

Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes
por: Weykamp, Fabian, et al.
Publicado: (2021)

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)
por: Regnery, Sebastian, et al.
Publicado: (2022)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
por: Hoegen, P., et al.
Publicado: (2022)

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
por: Regnery, Sebastian, et al.
Publicado: (2022)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
por: Hoegen, Philipp, et al.
Publicado: (2022)

Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2023)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Quality assurance for on‐table adaptive magnetic resonance guided radiation therapy: A software tool to complement secondary dose calculation and failure modes discovered in clinical routine
por: Rippke, Carolin, et al.
Publicado: (2022)

MR-guidance in clinical reality: current treatment challenges and future perspectives
por: Corradini, S., et al.
Publicado: (2019)

Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy
por: Regnery, Sebastian, et al.
Publicado: (2023)

First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany
por: Klüter, Sebastian, et al.
Publicado: (2020)

Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity
por: Ristau, J., et al.
Publicado: (2021)

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
por: Rühle, Alexander, et al.
Publicado: (2019)

MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy?
por: Hörner-Rieber, Juliane, et al.
Publicado: (2021)

Detecting and Locating the Site of Local Relapse Using (18)F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients—Potential Impact on PSMA-Guided Radiation Therapy
por: Koerber, S. A., et al.
Publicado: (2022)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer
por: Ristau, J., et al.
Publicado: (2020)

A practical implementation of risk management for the clinical introduction of online adaptive Magnetic Resonance-guided radiotherapy
por: Klüter, Sebastian, et al.
Publicado: (2021)

In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
por: John, Caroline, et al.
Publicado: (2021)

Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma
por: König, Laila, et al.
Publicado: (2020)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques
por: Bodensohn, Raphael, et al.
Publicado: (2023)

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
por: Schröder, Christina, et al.
Publicado: (2019)

Leaf-individual calibration for a double stack multileaf collimator in photon radiotherapy
por: Rippke, Carolin, et al.
Publicado: (2023)

Current status and recent advances in resection cavity irradiation of brain metastases
por: Minniti, Giuseppe, et al.
Publicado: (2021)

Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis
por: Hadi, Indrawati, et al.
Publicado: (2020)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

Contextualising Smiles: Is Perception of Smile Genuineness Influenced by Situation and Culture?
por: Mui, Phoebe H. C., et al.
Publicado: (2020)

Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer—Experiences from a Single Institution
por: Hörner-Rieber, Juliane, et al.
Publicado: (2017)

Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk
por: König, Laila, et al.
Publicado: (2020)

Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands
por: Schmid, Maximilian P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o0n01cs3k865efovd8mejdbedm